SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have full text access to this Open Access content1
    Maria R. Castrucci, Marzia Facchini, Giuseppina Di Mario, Bruno Garulli, Ester Sciaraffia, Monica Meola, Concetta Fabiani, Maria A. Marco, Paolo Cordioli, Antonio Siccardi, Yoshihiro Kawaoka, Isabella Donatelli, Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian ‘avian-like’ H1N1 swine viruses in mice, Influenza and Other Respiratory Viruses, 2014, 8, 3
  2. 2
    J. C. Phillips, Punctuated Evolution of Influenza Virus Neuraminidase (A/H1N1) under Opposing Migration and Vaccination Pressures, BioMed Research International, 2014, 2014, 1

    CrossRef

  3. 3
    M. S. Miller, T. Tsibane, F. Krammer, R. Hai, S. Rahmat, C. F. Basler, P. Palese, 1976 and 2009 H1N1 Influenza Virus Vaccines Boost Anti-Hemagglutinin Stalk Antibodies in Humans, Journal of Infectious Diseases, 2013, 207, 1, 98

    CrossRef

  4. 4
    R. A. Medina, S. Stertz, B. Manicassamy, P. Zimmermann, X. Sun, R. A. Albrecht, H. Uusi-Kerttula, O. Zagordi, R. B. Belshe, S. E. Frey, T. M. Tumpey, A. Garcia-Sastre, Glycosylations in the Globular Head of the Hemagglutinin Protein Modulate the Virulence and Antigenic Properties of the H1N1 Influenza Viruses, Science Translational Medicine, 2013, 5, 187, 187ra70

    CrossRef

  5. 5
    Yong-Li Xiao, John C Kash, Stephen B Beres, Zong-Mei Sheng, James M Musser, Jeffery K Taubenberger, High-throughput RNA sequencing of a formalin-fixed, paraffin-embedded autopsy lung tissue sample from the 1918 influenza pandemic, The Journal of Pathology, 2013, 229, 4
  6. 6
    P. S. Wikramaratna, M. Sandeman, M. Recker, S. Gupta, The antigenic evolution of influenza: drift or thrift?, Philosophical Transactions of the Royal Society B: Biological Sciences, 2013, 368, 1614, 20120200

    CrossRef

  7. 7
    M. L. B. Hillaire, S. E. van Trierum, J. H. C. M. Kreijtz, R. Bodewes, M. M. Geelhoed-Mieras, N. J. Nieuwkoop, R. A. M. Fouchier, T. Kuiken, A. D. M. E. Osterhaus, G. F. Rimmelzwaan, Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells, Journal of General Virology, 2011, 92, 10, 2339

    CrossRef

  8. 8
    Day-Yu Chao, Kuang-Fu Cheng, Tsai-Chung Li, Trong-Neng Wu, Chiu-Ying Chen, Chen-An Tsai, Jin-Hua Chen, Hsien-Tsai Chiu, Jang-Jih Lu, Mei-Chi Su, Yu-Hsin Liao, Wei-Cheng Chan, Ying-Hen Hsieh, Factors associated with infection by 2009 pandemic H1N1 influenza virus during different phases of the epidemic, International Journal of Infectious Diseases, 2011, 15, 10, e695

    CrossRef

  9. You have full text access to this Open Access content9
    Judith D. Easterbrook, John C. Kash, Zong-Mei Sheng, Li Qi, Jin Gao, Edwin D. Kilbourne, Maryna C. Eichelberger, Jeffery K. Taubenberger, Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infection, Influenza and Other Respiratory Viruses, 2011, 5, 3
  10. 10
    J. K. Taubenberger, D. M. Morens, R. M. Krause, A. S. Fauci, In Memoriam: Edwin D. Kilbourne, MD, 1920-2011, Journal of Infectious Diseases, 2011, 204, 2, 185

    CrossRef

  11. 11
    Rafael A. Medina, Adolfo García-Sastre, Influenza A viruses: new research developments, Nature Reviews Microbiology, 2011, 9, 8, 590

    CrossRef

  12. 12
    Jeffery K. Taubenberger, John C. Kash, Insights on influenza pathogenesis from the grave, Virus Research, 2011, 162, 1-2, 2

    CrossRef

  13. 13
    Derek T O’Hagan, Rino Rappuoli, Ennio De Gregorio, Theodore Tsai, Giuseppe Del Giudice, MF59 adjuvant: the best insurance against influenza strain diversity, Expert Review of Vaccines, 2011, 10, 4, 447

    CrossRef

  14. 14
    David M. Morens, Jeffery K. Taubenberger, Pandemic influenza: certain uncertainties, Reviews in Medical Virology, 2011, 21, 5
  15. 15
    Yasushi Ohkusa, Tamie Sugawara, Kiyosu Taniguchi, Nobuhiko Okabe, Real-time estimation and prediction for pandemic A/H1N1(2009) in Japan, Journal of Infection and Chemotherapy, 2011, 17, 4, 468

    CrossRef

  16. 16
    Matthew J. Memoli, Severity of pH1N1 influenza A, Critical Care Medicine, 2011, 39, 4, 926

    CrossRef

  17. 17
    Ji-Young Min, Grace L Chen, Celia Santos, Elaine W Lamirande, Yumiko Matsuoka, Kanta Subbarao, Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets, Virology, 2010, 408, 1, 128

    CrossRef

  18. 18
    T. Rowe, D. Banner, A. Farooqui, D. C. K. Ng, A. A. Kelvin, S. Rubino, S. S. H. Huang, Y. Fang, D. J. Kelvin, In vivo ribavirin activity against severe pandemic H1N1 influenza A/Mexico/4108/2009, Journal of General Virology, 2010, 91, 12, 2898

    CrossRef

  19. 19
    Matthew J. Memoli, pH1N1 influenza A: Timing is everything*, Critical Care Medicine, 2010, 38, 10, 2081

    CrossRef

  20. 20
    David M. Morens, Donald S. Burke, Scott B. Halstead, The Wages of Original Antigenic Sin, Emerging Infectious Diseases, 2010, 16, 6, 1023

    CrossRef

  21. 21
    Stacey Schultz-Cherry, Jeremy C. Jones, 2010,

    CrossRef